Adaptiiv Medical Technologies a Between a collaboration with Varian, a Siemens Healthineers company, and HP to support cancer treatment.
The collaboration will leverage 3D printed medical devices to improve access to personalized cancer care for US patients.
The move comes after Adaptiiv obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Adaptiiv On Demand service, which produces and supplies patient-specific 3D printed medical devices.
These devices match the patient’s anatomy to improve the accuracy of dose delivery.
Adaptiiv’s software platform can work with 3D printing to develop medical devices that can be used in radiation oncology.
The partnership aims to leverage the HP Multi Jet Fusion platform, which can help manufacture 3D-printed medical devices for use in high-throughput radiation oncology.
On the other hand, Varian will work to expand access to patient-specific 3D printed medical devices.
Adaptiiv CEO Alex Dunphy said, “This is an important step in Adaptiiv’s vision to democratize radiation therapy personalization.
“Collaborating with brands such as HP and Varian, synonymous with quality and innovation, will ensure that our solutions reach patients around the world.
“The last mile of radiation therapy must evolve, and our solutions provide greater access to personalized care while improving treatment and creating more efficient workflows for cancer centers around the world.”
HP’s Vice President of 3D Printing, Louis Kim, said, “The combined technology scale of HP and Varian, along with Adaptiiv’s industry-leading customization workflow, provides the enhanced solution that clinicians and patients deserve.
“HP is proud to be part of this collaboration to help advance cancer treatment around the world.”